ArticleNeoplasia (New York, N.Y.)2014

Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.

James M Lindberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.